<DOC>
	<DOCNO>NCT00873769</DOCNO>
	<brief_summary>The objective trial ass pharmacokinetics single dose 10 mg Staccato Loxapine administer smoker compare nonsmoker .</brief_summary>
	<brief_title>Staccato Loxapine PK Smokers Nonsmokers</brief_title>
	<detailed_description>Pharmacokinetics sedation pharmacodynamics study use visual analog scale study male female adult subject ( nonsmoker smoker ) follow single dose 10 mg inhale loxapine . Blood sample draw predose , 30 second , 1 , 2 , 3 , 10 , 30 , 60 minute , 2 , 6 , 12 , 24 hour dose . Loxapine 8-OH-loxapine analyze use reverse-phase liquid chromatography couple tandem mass spectrometer .</detailed_description>
	<mesh_term>Loxapine</mesh_term>
	<criteria>Normal spirometry screen good general health determine complete medical history , physical examination , 12lead ECG , blood chemistry profile , hematology , urinalysis , Smokers must history smoking &gt; 15 cigarettes/day currently least last 2 year , Nonsmokers must never smoke &gt; 5 cigarettes/day smoke least last 2 year . Any acute illness 5 day , Use bronchodilator treatment wheeze within 12 month , OR Any disease condition , history , physical examination , laboratory abnormality would present undue risk subject , may confound interpretation study result .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Staccato Loxapine</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>smoker</keyword>
	<keyword>non-smokers</keyword>
</DOC>